Personalized care in Radiation Oncology

During the first six years of its operations, RTsafe has focused mainly on brain cancer. PseudoPatient, nominated as one of the 100 most technologically significant products in 2019, is the personalized care solution that RTsafe has developed, patented and commercialized for brain tumor patients, following extensive R&D and tens of scientific publications. It is a 510k-FDA cleared solution that is already improving the lives of patients globally in a totally personalized way.

Our next core milestones are to make our personalized care solutions easily accessible to millions of cancer patients globally and to keep innovating and developing equivalent solutions for cancer types other than brain tumors.

At RTsafe, our goal is to develop and implement high-end technologies to achieve maximum treatment efficiency combined with maximum patient safety, allowing the patient to return to life’s activities, following an effective treatment.

Whatever role you play in the treatment cycle, RTsafe’s products and services can help you. Click on the button below to learn more about the benefits we can bring to you and your colleagues.

Find out how RTsafe can help you

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

The PseudoPatient® solution

Play Video

See what's new at RTsafe

RTsafe to exhibit at ISRS Congress 2022 in Milan

RTsafe to exhibit at ISRS Congress 2022 in Milan

Conferences - Tradeshows
RTsafe is pleased to announce its participation in the meeting of the International Stereotactic Radiosurgery Society Congress (ISRS), which takes place in Milan,...
Read More
Webinar – Dosimetry audit on stereotactic radiosurgery applications: Clinical experience of succeSRS

Webinar – Dosimetry audit on stereotactic radiosurgery applications: Clinical experience of succeSRS

Webinars
Join our Webinar on Wednesday, June 8 at 17:00 EEST lead by Andriana Peraticou, Director of Medical Physics at the...
Read More
RTsafe to Exhibit at ESTRO 2022 in Copenhagen

RTsafe to Exhibit at ESTRO 2022 in Copenhagen

Conferences - Tradeshows
The annual congress of ESTRO will take place 6-10 May 2022 in Copenhagen, Denmark. ESTRO offers oncology professionals the chance to share...
Read More

Testimonials

Download our complete
product cataloque.

Request a quote

End Users

Customers Placeholder
Customers
ΕΣΠΑ Banner